Market Tracker

05/26 5:16pm ET

PDL BioPharma Inc (NASDAQ:PDLI)

2.39
Delayed Data
As of May 26
 +0.05 / +2.14%
Today’s Change
1.93
Today|||52-Week Range
3.77
+12.74%
Year-to-Date
No recent news for PDL BioPharma Inc.

Today’s Trading

Previous close2.34
Today’s open2.33
Day’s range2.33 - 2.39
Volume903,999
Average volume (3 months)1,790,118
Market cap$384.8M
Dividend yield8.37%
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-80.79%
Earnings growth (this year)-47.01%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)-59.03%
P/E ratio26.6
Price/Sales1.45
Price/Book0.53

Competitors

 Today’s
change
Today’s
% change
CYADCelyad SA+0.90+2.29%
MCRBSeres Therapeutics I...-0.19-1.99%
SYRSSyros Pharmaceutical...-0.41-2.67%
BLCMBellicum Pharmaceuti...-0.36-2.95%
Data as of 3:59pm ET, 05/26/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.09
Annual revenue (last year)$239.7M
Annual profit (last year)$63.6M
Net profit margin26.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts